Trial Profile
A comparison trial of diagnostic performance of simultaneous 68Gallium-HBED-CC-PSMA PET and multiparametric MRI with results of multiparametric MRI and PET alone.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Jul 2016
Price :
$35
*
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- 04 Jul 2016 New trial record